ATP5G3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.758000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.829600E-01
Normal-vs-Stage2
2.623000E-01
Normal-vs-Stage3
7.553800E-01
Normal-vs-Stage4
4.283400E-01
Stage1-vs-Stage2
8.719800E-01
Stage1-vs-Stage3
5.258800E-01
Stage1-vs-Stage4
4.027800E-01
Stage2-vs-Stage3
3.904800E-01
Stage2-vs-Stage4
2.973800E-02
Stage3-vs-Stage4
9.684600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.840400E-01
Normal-vs-AfricanAmerican
6.768000E-02
Normal-vs-Asian
2.932400E-01
Caucasian-vs-AfricanAmerican
5.279600E-01
Caucasian-vs-Asian
4.532200E-01
AfricanAmerican-vs-Asian
9.708200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.695030E-01
Normal-vs-Female
3.704400E-01
Male-vs-Female
9.988000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.109200E-01
Normal-vs-Age(41-60Yrs)
9.961700E-02
Normal-vs-Age(61-80Yrs)
3.635600E-01
Normal-vs-Age(81-100Yrs)
7.867900E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.488800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.559800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.395800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.700800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.110800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.050200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.872800E-01
Normal-vs-Daily Drinker
3.091400E-01
Normal-vs-Weekly Drinker
3.794000E-01
Normal-vs-Occasional Drinker
8.083700E-02
Normal-vs-Social Drinker
2.192600E-01
Non Drinker-vs-Daily Drinker
6.447400E-01
Non Drinker-vs-Weekly Drinker
2.700800E-01
Non Drinker-vs-Occasional Drinker
2.650400E-01
Non Drinker-vs-Social Drinker
4.651000E-01
Daily Drinker-vs-Weekly Drinker
3.690800E-01
Daily Drinker-vs-Occasional Drinker
5.588000E-01
Daily Drinker-vs-Social Drinker
7.766400E-01
Weekly Drinker-vs-Occasional Drinker
5.068000E-01
Weekly Drinker-vs-Social Drinker
4.529800E-01
Occasional Drinker-vs-Social Drinker
8.005600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.336400E-01
Normal-vs-Grade 2
3.668000E-01
Normal-vs-Grade 3
7.038400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.891700E-02
Grade 1-vs-Grade 3
5.839600E-02
Grade 1-vs-Grade 4
6.336400E-01
Grade 2-vs-Grade 3
6.743600E-01
Grade 2-vs-Grade 4
3.668000E-01
Grade 3-vs-Grade 4
7.038400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.933800E-01
Normal-vs-NonDiabetic
2.871200E-01
Diabetic-vs-NonDiabetic
4.185600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.225900E-02
Normal-vs-NoPancreatitis
3.277000E-01
Pancreatitis-vs-NoPancreatitis
3.530200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.463160E-01
Normal-vs-N1
2.943600E-01
N0-vs-N1
7.550600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.885010E-01
Normal-vs-TP53-NonMutant
5.626400E-01
TP53-Mutant-vs-TP53-NonMutant
1.862150E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
